CL2004001124A1 - DEVICE FOR ORAL TREATMENT THAT INCLUDES A THIN BARRIER LAYER AND A COMPOSITION THAT INCLUDES AN ACTIVE AGENT AND A TISSULAR ADHESION AGENT, WHICH ACTS AS A SKELETON TO MAINTAIN THE FORM OF A LAYER TRAY TO THE LAYER, - Google Patents

DEVICE FOR ORAL TREATMENT THAT INCLUDES A THIN BARRIER LAYER AND A COMPOSITION THAT INCLUDES AN ACTIVE AGENT AND A TISSULAR ADHESION AGENT, WHICH ACTS AS A SKELETON TO MAINTAIN THE FORM OF A LAYER TRAY TO THE LAYER,

Info

Publication number
CL2004001124A1
CL2004001124A1 CL2004001124A CL2004001124A CL2004001124A1 CL 2004001124 A1 CL2004001124 A1 CL 2004001124A1 CL 2004001124 A CL2004001124 A CL 2004001124A CL 2004001124 A CL2004001124 A CL 2004001124A CL 2004001124 A1 CL2004001124 A1 CL 2004001124A1
Authority
CL
Chile
Prior art keywords
layer
tissular
skeleton
acts
maintain
Prior art date
Application number
CL2004001124A
Other languages
Spanish (es)
Inventor
M Allred Dan E Fischer Peter
Original Assignee
Ultradent Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/444,242 external-priority patent/US7040897B2/en
Priority claimed from US10/446,235 external-priority patent/US7074042B2/en
Priority claimed from US10/637,237 external-priority patent/US7059857B2/en
Application filed by Ultradent Products Inc filed Critical Ultradent Products Inc
Publication of CL2004001124A1 publication Critical patent/CL2004001124A1/en

Links

CL2004001124A 2003-05-23 2004-05-19 DEVICE FOR ORAL TREATMENT THAT INCLUDES A THIN BARRIER LAYER AND A COMPOSITION THAT INCLUDES AN ACTIVE AGENT AND A TISSULAR ADHESION AGENT, WHICH ACTS AS A SKELETON TO MAINTAIN THE FORM OF A LAYER TRAY TO THE LAYER, CL2004001124A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/444,242 US7040897B2 (en) 2003-05-23 2003-05-23 Thin, flexible membrane dental trays and systems and methods utilizing such trays
US10/446,235 US7074042B2 (en) 2003-05-27 2003-05-27 Tray-like dental bleaching devices having a barrier layer and a substantially solid bleaching composition
US10/637,237 US7059857B2 (en) 2003-05-27 2003-08-08 Substantially solid desensitizing compositions and devices having a tray-like configuration and methods of manufacturing and using such compositions and devices

Publications (1)

Publication Number Publication Date
CL2004001124A1 true CL2004001124A1 (en) 2005-04-22

Family

ID=40261291

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2004001124A CL2004001124A1 (en) 2003-05-23 2004-05-19 DEVICE FOR ORAL TREATMENT THAT INCLUDES A THIN BARRIER LAYER AND A COMPOSITION THAT INCLUDES AN ACTIVE AGENT AND A TISSULAR ADHESION AGENT, WHICH ACTS AS A SKELETON TO MAINTAIN THE FORM OF A LAYER TRAY TO THE LAYER,

Country Status (1)

Country Link
CL (1) CL2004001124A1 (en)

Similar Documents

Publication Publication Date Title
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
CO6501159A2 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION OF NITAZOXANIDA
BRPI0818673A2 (en) combination therapy of an anti-cd20 type ii antibody with an anti-bcl-2 active agent
CL2007002095A1 (en) Topical pharmaceutical composition comprising 1- (2-methylpropyl) -1h-imidazo [4,5-c] quinolin-4-amine; packaged composition; method to sterilize it; Useful to heal tissue where the dermis has torn.
MY158687A (en) Micro-needle device and preparation method
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
WO2007130841A3 (en) Oral compositions comprising siloxane polymers
IL164165A (en) Oral dosage form comprising alkalizing agent, azithromycin, glyceride and poloxamer
WO2006119958A3 (en) Use of flibanserin in the treatment of chronic pain
CL2013001136A1 (en) A phosphodiesterase 7 (pde7) inhibitory agent to be used in the treatment or reduction of the possibility of an addiction; and pharmaceutical composition, unit dosage form and pharmaceutical kit including phosphodiesterase 7 inhibitor (pde7) and an additional therapeutic agent.
AR047841A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE-INFLAMMATORY DISORDERS
BRPI0815577A2 (en) FOXM1 PEPTIDE AND MEDICAL AGENT UNDERSTANDING THE SAME.
ATE474561T1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION FOR ORAL, OROMUCOSAL OR SUBLINGUAL ADMINISTRATION OF AGOMELATIN
WO2010041017A3 (en) Chewable gelled emulsions
ATE483497T1 (en) ORAL CARE COMPOSITIONS
FI20045070A0 (en) Acceleration client integrated into one application
BRPI0816236A2 (en) Cdh3 peptide and medicinal agent containing the same
DK1680128T3 (en) Myo-inositol hexaphosphate for topical use
AR052322A1 (en) N-BENZOIL-ESTAUROSPORINE COMPOUNDS, PROCESSES FOR PREPARATION AND PHARMACEUTICAL COMPOSITION
CL2007003643A1 (en) PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS.
AR065342A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING QUETIAPINE FUMARATE
DK1624869T3 (en) DOSAGE FORM CONTAINING PANTOPRAZOL AS ACTIVE INGREDIENT
AR028525A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF LERISETRON
IS8559A (en) Medicinal composition against fungal bacteria
CL2004001124A1 (en) DEVICE FOR ORAL TREATMENT THAT INCLUDES A THIN BARRIER LAYER AND A COMPOSITION THAT INCLUDES AN ACTIVE AGENT AND A TISSULAR ADHESION AGENT, WHICH ACTS AS A SKELETON TO MAINTAIN THE FORM OF A LAYER TRAY TO THE LAYER,